Jilin Zixin Pharmaceutical Co., Ltd. and all members of the board guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Special Reminder:
- According to Article 9.2.1 of the "Shenzhen Stock Exchange Stock Listing Rules (2023 Revision)," as of June 7, 2023, the company's stock closing price was 0.49 CNY/share, and it has been below 1 CNY for fourteen consecutive trading days. Even if the stock experiences a price increase for the next six trading days, it will still trigger delisting indicators due to the stock price being below 1 CNY for twenty consecutive trading days. If this occurs, the Shenzhen Stock Exchange will make a delisting decision within the specified period, and the stock will not enter a delisting adjustment period.
- According to Article 9.2.3 of the "Shenzhen Stock Exchange Stock Listing Rules (2023 Revision)," the company must disclose a risk warning announcement regarding the possibility of delisting due to the stock price falling below par value. This announcement will be disclosed daily until the situation is resolved or until the Shenzhen Stock Exchange makes a delisting decision. Investors are advised to invest rationally and pay attention to risks.